NCT00472381View on ClinicalTrials.gov

Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Acute StrokeAcute Cerebral Ischemia
Interventions
DRUG

Insulin

Insulin

Trial Locations (1)

75013

AP-HP Urgences cerebro vasculaires La Pitié Salpétrière, Poissy

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00472381 - Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter